{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "09",
                "@timestamp": "2022-02-09T14:59:48.000048-05:00",
                "@year": "2022",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Ratchadapiseksompotch Fund"},
                {"xocs:funding-agency-matched-string": "Research Unit in Translational Hematology"},
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Thailand Research Fund",
                    "xocs:funding-agency-acronym": "TRF",
                    "xocs:funding-agency": "Thailand Research Fund",
                    "xocs:funding-id": "RDG6050109",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004396",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-acronym": "MDCU",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-id": "RA63/087",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-01-14T23:33:16.515Z",
            "xocs:funding-text": [
                {"$": "This research was supported by a Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University,grant number RA63/087 (S.H. and C.P.), a grant from Thailand Research Fund, grant number RDG6050109(C.P.), and a grant from Research Unit in TranslationalHematology (K.W.)"},
                {"$": "This research was supported by a Ratchadapiseksompotch"}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "113019942"
                                },
                                {"@afid": "60022183"}
                            ],
                            "@affiliation-instance-id": "2016156980-2134dd8968829df6bdee40c6855a44ae",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [
                            {
                                "ce:given-name": "Saroj",
                                "preferred-name": {
                                    "ce:given-name": "Saroj",
                                    "ce:initials": "S.",
                                    "ce:surname": "Hattakitpanitchakul",
                                    "ce:indexed-name": "Hattakitpanitchakul S."
                                },
                                "@author-instance-id": "2016156980-a5c4325ccbdcade3218c186b95883377",
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Hattakitpanitchakul",
                                "@auid": "57406571100",
                                "ce:indexed-name": "Hattakitpanitchakul S."
                            },
                            {
                                "ce:given-name": "Sirorat",
                                "preferred-name": {
                                    "ce:given-name": "Sirorat",
                                    "ce:initials": "S.",
                                    "ce:surname": "Kobbuaklee",
                                    "ce:indexed-name": "Kobbuaklee S."
                                },
                                "@author-instance-id": "2016156980-dd4b73b1d3ed8ebe2ce9329013c99dc6",
                                "@seq": "2",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kobbuaklee",
                                "@auid": "57211805681",
                                "ce:indexed-name": "Kobbuaklee S."
                            },
                            {
                                "ce:given-name": "Kitsada",
                                "preferred-name": {
                                    "ce:given-name": "Kitsada",
                                    "ce:initials": "K.",
                                    "ce:surname": "Wudhikarn",
                                    "ce:indexed-name": "Wudhikarn K."
                                },
                                "@author-instance-id": "2016156980-21650914613b525f2d0a622de4c1ba63",
                                "@seq": "3",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wudhikarn",
                                "@auid": "37091810400",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            {
                                "ce:given-name": "Chantana",
                                "preferred-name": {
                                    "ce:given-name": "Chantana",
                                    "ce:initials": "C.",
                                    "ce:surname": "Polprasert",
                                    "ce:indexed-name": "Polprasert C."
                                },
                                "@author-instance-id": "2016156980-b6ddbe6fd298178cd78da47eeec738e7",
                                "@seq": "4",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Polprasert",
                                "@auid": "56601214400",
                                "ce:indexed-name": "Polprasert C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Research Unit in Translational Hematology"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "123458373"
                            },
                            "@affiliation-instance-id": "2016156980-92f0b2c4b5d4857788f46d63d4e045c7",
                            "ce:source-text": "Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "123458373"
                        },
                        "author": [
                            {
                                "ce:given-name": "Sirorat",
                                "preferred-name": {
                                    "ce:given-name": "Sirorat",
                                    "ce:initials": "S.",
                                    "ce:surname": "Kobbuaklee",
                                    "ce:indexed-name": "Kobbuaklee S."
                                },
                                "@author-instance-id": "2016156980-dd4b73b1d3ed8ebe2ce9329013c99dc6",
                                "@seq": "2",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kobbuaklee",
                                "@auid": "57211805681",
                                "ce:indexed-name": "Kobbuaklee S."
                            },
                            {
                                "ce:given-name": "Kitsada",
                                "preferred-name": {
                                    "ce:given-name": "Kitsada",
                                    "ce:initials": "K.",
                                    "ce:surname": "Wudhikarn",
                                    "ce:indexed-name": "Wudhikarn K."
                                },
                                "@author-instance-id": "2016156980-21650914613b525f2d0a622de4c1ba63",
                                "@seq": "3",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wudhikarn",
                                "@auid": "37091810400",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            {
                                "ce:given-name": "Chantana",
                                "preferred-name": {
                                    "ce:given-name": "Chantana",
                                    "ce:initials": "C.",
                                    "ce:surname": "Polprasert",
                                    "ce:indexed-name": "Polprasert C."
                                },
                                "@author-instance-id": "2016156980-b6ddbe6fd298178cd78da47eeec738e7",
                                "@seq": "4",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Polprasert",
                                "@auid": "56601214400",
                                "ce:indexed-name": "Polprasert C."
                            }
                        ]
                    }
                ],
                "citation-title": "Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes",
                "abstracts": "© This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License.Introduction: Erythropoiesis stimulating agents (ESAs) represents the principal treatments for anemia in patients with lower-risk myelodysplastic syndromes (MDS). Pre-treatment erythropoietin (EPO) level and previous bloodtransfusion requirement are the two major predictors for response to ESAs. However, most evidence was derivedfrom Western countries whereas there have been limited data in patients with Asian background. Methods: Weretrospectively collected data on patients with low-risk MDS who received ESAs. Erythroid response was evaluatedaccording to IWG 2006 criteria. MDS subtypes, r-IPSS, baseline hemoglobin (Hb), ESAs dosage and erythropoietinlevel were reviewed from medical records. Gene mutations were analyzed in patients\u2019 blood or bone marrow atdiagnosis by 40-gene myeloid panel targeted sequencing. Clinical and laboratory parameters were compared betweenerythroid responder and non-responder groups. Results: A total of 47 patients were recruited in the study. The medianage at diagnosis of the patients in this cohort was 77 years (IQR, 70-83) and 44.7% were male. The median revisedinternational prognostic scoring system (R-IPSS) score of patients was 2.5. Response rate to ESAs was 46.8% (22/47).Median EPO level in responders was significantly lower than non-responders (27.7 vs. 59.1 U/L, p=0.02). MedianESAs dosage in responder group was 30,000 units per week. Cytogenetic abnormalities were detected in 27.3% and24% of the responder and non-responder groups, respectively. Of 22 patients with available 40 gene mutation targetedsequencing, ASXL1, IDH2 and TET2 represented the 3 most common mutations and were found in 22%, 22% and17%, respectively. There were no differences in cytogenetic abnormalities and gene mutations between groups. Patientswho responded to ESAs showed a higher 5-year overall survival (OS) compared to non-responders (5-year OS 75%vs. 60.9%; p=0.008). Conclusion:We conclude that a low serum EPO level is a predictive factor for responsiveness toESAs in Asian patients with low-risk MDS",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"},
                            {"$": "King Chulalongkorn Memorial Hospital"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Chantana",
                        "ce:initials": "C.",
                        "ce:surname": "Polprasert",
                        "ce:indexed-name": "Polprasert C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Erythropoiesis stimulating agents",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Erythropoietin level",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Gene mutations",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Low",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Risk myelodysplastic syndromes",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Asian Pac. J. Cancer Preven.",
                    "website": {"ce:e-address": {
                        "$": "http://journal.waocp.org/?_action=article&vol=3118&issue=3124&max_rows=100",
                        "@type": "email"
                    }},
                    "@country": "tha",
                    "translated-sourcetitle": {
                        "$": "Asian Pacific Journal of Cancer Prevention",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "2476762X",
                            "@type": "electronic"
                        },
                        {
                            "$": "15137368",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "22",
                            "@issue": "12"
                        },
                        "pagerange": {
                            "@first": "4037",
                            "@last": "4042"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Asian Pacific Organization for Cancer Prevention"},
                    "sourcetitle": "Asian Pacific Journal of Cancer Prevention",
                    "@srcid": "40173",
                    "publicationdate": {
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2021"
                        }
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2713"},
                                {"$": "2730"},
                                {"$": "2739"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "37292-90-3",
                                    "chemical-name": "dioxygenase"
                                },
                                {
                                    "cas-registry-number": "11096-26-7",
                                    "chemical-name": "erythropoietin"
                                },
                                {
                                    "cas-registry-number": "9001-58-5",
                                    "chemical-name": "isocitrate dehydrogenase"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "ASXL1 protein, human"},
                                {"chemical-name": "Dioxygenases"},
                                {"chemical-name": "DNA-Binding Proteins"},
                                {"chemical-name": "EPO protein, human"},
                                {"chemical-name": "Erythropoietin"},
                                {"chemical-name": "Hematinics"},
                                {"chemical-name": "IDH2, human"},
                                {"chemical-name": "Isocitrate Dehydrogenase"},
                                {"chemical-name": "Repressor Proteins"},
                                {"chemical-name": "TET2 protein, human"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This research was supported by a Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University,grant number RA63/087 (S.H. and C.P.), a grant from Thailand Research Fund, grant number RDG6050109(C.P.), and a grant from Research Unit in TranslationalHematology (K.W.)",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-id": "6050109",
                        "grant-acronym": "TRF",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Thailand Research Fund"
                        },
                        "grant-agency-id": "501100004396"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "14",
                    "@timestamp": "BST 08:24:41",
                    "@year": "2022",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2016156980",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "937828282",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2022018833",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20220106304",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20220139597",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2022007294",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "20219022960244",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85122570499",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85122570499",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "636969095",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "34967586",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "79419699",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.31557/APJCP.2021.22.12.4037"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "15",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Arber DA, Orazi A, Hasseιjian R, et al (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127, 2391-405.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84974560145",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "127"},
                                "pagerange": {
                                    "@first": "2391",
                                    "@last": "2405"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DA",
                                        "@_fa": "true",
                                        "ce:surname": "Arber",
                                        "ce:indexed-name": "Arber DA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Orazi",
                                        "ce:indexed-name": "Orazi A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Hasseιjian",
                                        "ce:indexed-name": "Hasseiotajian R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Arber DA, Orazi A, Hasseιjian R, et al (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127, 2391-405."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Buckstein R, Balleari E, Wells R, et al (2017). ITACA: A new validated international erythropoietic stimulating agentresponse score that further refines the predictive power of previous scoring systems. Am JHematol, 92, 1037-46.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "ITACA: A new validated international erythropoietic stimulating agentresponse score that further refines the predictive power of previous scoring systems"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85026453194",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "92"},
                                "pagerange": {
                                    "@first": "1037",
                                    "@last": "1046"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Buckstein",
                                        "ce:indexed-name": "Buckstein R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Balleari",
                                        "ce:indexed-name": "Balleari E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Wells",
                                        "ce:indexed-name": "Wells R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am JHematol"
                        },
                        "ce:source-text": "Buckstein R, Balleari E, Wells R, et al (2017). ITACA: A new validated international erythropoietic stimulating agentresponse score that further refines the predictive power of previous scoring systems. Am JHematol, 92, 1037-46."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cheson BD, Greenberg PL, Bennett JM, et al (2006). Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood, 108, 419-25.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33745968917",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "108"},
                                "pagerange": {
                                    "@first": "419",
                                    "@last": "425"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BD",
                                        "@_fa": "true",
                                        "ce:surname": "Cheson",
                                        "ce:indexed-name": "Cheson BD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PL",
                                        "@_fa": "true",
                                        "ce:surname": "Greenberg",
                                        "ce:indexed-name": "Greenberg PL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Bennett",
                                        "ce:indexed-name": "Bennett JM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Cheson BD, Greenberg PL, Bennett JM, et al (2006). Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood, 108, 419-25."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Christina Ferrone HW, Laura S, Brooke S, et al (2018). Validation and clinical impact of the oncomine myeloid targeted DNA and RNA ion semiconductor sequencing assay. Blood, 132, 5523.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Validation and clinical impact of the oncomine myeloid targeted DNA and RNA ion semiconductor sequencing assay"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85120080185",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "132"},
                                "pagerange": {"@first": "5523"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HW",
                                        "@_fa": "true",
                                        "ce:surname": "Christina Ferrone",
                                        "ce:indexed-name": "Christina Ferrone HW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Laura",
                                        "ce:indexed-name": "Laura S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Brooke",
                                        "ce:indexed-name": "Brooke S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Christina Ferrone HW, Laura S, Brooke S, et al (2018). Validation and clinical impact of the oncomine myeloid targeted DNA and RNA ion semiconductor sequencing assay. Blood, 132, 5523."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Greenberg PL, Stone RM,Al-KaliA, et al (2021). Myelodysplastic Syndromes, Version 3.2021. Clin Pract Guidelines Oncol, 15.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Myelodysplastic Syndromes, Version 3.2021"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85122568962",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"voliss": {"@volume": "15"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PL",
                                        "@_fa": "true",
                                        "ce:surname": "Greenberg",
                                        "ce:indexed-name": "Greenberg PL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RM",
                                        "@_fa": "true",
                                        "ce:surname": "Stone",
                                        "ce:indexed-name": "Stone RM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Kali",
                                        "ce:indexed-name": "Al-Kali A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pract Guidelines Oncol"
                        },
                        "ce:source-text": "Greenberg PL, Stone RM,Al-KaliA, et al (2021). Myelodysplastic Syndromes, Version 3.2021. Clin Pract Guidelines Oncol, 15."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Hellstrom-Lindberg E, Negrin R, Stein R, et al ( 1997). Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br JHaematol, 99, 344-51. Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, et al (2003). A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin+granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol, 120, 1037-46.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br JHaematol, 99, 344-51. Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, et al"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0030682515",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "(2003). A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin+granulocyte colony-stimulating factor: significant effects on quality of life. 120, 1037-46",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Hellstrom-Lindberg",
                                        "ce:indexed-name": "Hellstrom-Lindberg E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Negrin",
                                        "ce:indexed-name": "Negrin R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Stein",
                                        "ce:indexed-name": "Stein R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Hellstrom-Lindberg E, Negrin R, Stein R, et al ( 1997). Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br JHaematol, 99, 344-51. Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, et al (2003). A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin+granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol, 120, 1037-46."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Horvath-Puho E, Suttorp MM, Frederiksen H, et al (2018). Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clin Epidemiol, 10, 1371-80.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85057750842",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "1371",
                                    "@last": "1380"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Horvath-Puho",
                                        "ce:indexed-name": "Horvath-Puho E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MM",
                                        "@_fa": "true",
                                        "ce:surname": "Suttorp",
                                        "ce:indexed-name": "Suttorp MM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Frederiksen",
                                        "ce:indexed-name": "Frederiksen H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Epidemiol"
                        },
                        "ce:source-text": "Horvath-Puho E, Suttorp MM, Frederiksen H, et al (2018). Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clin Epidemiol, 10, 1371-80."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kjeldsen L, Dybedal I, Hellstrom-Lindberg E, et al (2014). Guidelines for the diagnosis and treatment ofMyelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Nordic MDS Group. 2014.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85058436337",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Nordic MDS Group. 2014",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Kjeldsen",
                                        "ce:indexed-name": "Kjeldsen L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Dybedal",
                                        "ce:indexed-name": "Dybedal I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Hellstrom-Lindberg",
                                        "ce:indexed-name": "Hellstrom-Lindberg E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Guidelines for the diagnosis and treatment ofMyelodysplastic Syndromes and Chronic Myelomonocytic Leukemia"
                        },
                        "ce:source-text": "Kjeldsen L, Dybedal I, Hellstrom-Lindberg E, et al (2014). Guidelines for the diagnosis and treatment ofMyelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Nordic MDS Group. 2014."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lippi G, Franchini M, Favaloro EJ (2010). Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost, 36, 537-49.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Thrombotic complications of erythropoiesis-stimulating agents"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77954872334",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "537",
                                    "@last": "549"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Lippi",
                                    "ce:indexed-name": "Lippi G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Franchini",
                                    "ce:indexed-name": "Franchini M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "EJ",
                                    "@_fa": "true",
                                    "ce:surname": "Favaloro",
                                    "ce:indexed-name": "Favaloro EJ"
                                }
                            ]},
                            "ref-sourcetitle": "Semin Thromb Hemost"
                        },
                        "ce:source-text": "Lippi G, Franchini M, Favaloro EJ (2010). Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost, 36, 537-49."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Messa E, Gioia D, Masiera E, et al (2019). Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study. Haematologica, 104, 4-8.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85059279663",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "104"},
                                "pagerange": {
                                    "@first": "4",
                                    "@last": "8"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Messa",
                                        "ce:indexed-name": "Messa E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Gioia",
                                        "ce:indexed-name": "Gioia D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Masiera",
                                        "ce:indexed-name": "Masiera E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haematologica"
                        },
                        "ce:source-text": "Messa E, Gioia D, Masiera E, et al (2019). Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study. Haematologica, 104, 4-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Newman K, Maness-Harris L, El-Hamaidi I, et al (2012). Revisiting use of growth factors in myelodysplastic syndromes. Asian Pac J Cancer Prev, 13, 1081-91.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Revisiting use of growth factors in myelodysplastic syndromes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84873032058",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1081",
                                    "@last": "1091"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Newman",
                                        "ce:indexed-name": "Newman K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Maness-Harris",
                                        "ce:indexed-name": "Maness-Harris L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "El-Hamaidi",
                                        "ce:indexed-name": "El-Hamaidi I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Asian Pac J Cancer Prev"
                        },
                        "ce:source-text": "Newman K, Maness-Harris L, El-Hamaidi I, et al (2012). Revisiting use of growth factors in myelodysplastic syndromes. Asian Pac J Cancer Prev, 13, 1081-91."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Santini V (2011). Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes. Oncologist, 16, 35-42.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84856001005",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "35",
                                    "@last": "42"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "V",
                                "@_fa": "true",
                                "ce:surname": "Santini",
                                "ce:indexed-name": "Santini V"
                            }]},
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Santini V (2011). Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes. Oncologist, 16, 35-42."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Steensma DP, Bennett JM (2006). The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc, 81, 104-30.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "The myelodysplastic syndromes: diagnosis and treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "30144443817",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "81"},
                                "pagerange": {
                                    "@first": "104",
                                    "@last": "130"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DP",
                                    "@_fa": "true",
                                    "ce:surname": "Steensma",
                                    "ce:indexed-name": "Steensma DP"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JM",
                                    "@_fa": "true",
                                    "ce:surname": "Bennett",
                                    "ce:indexed-name": "Bennett JM"
                                }
                            ]},
                            "ref-sourcetitle": "Mayo Clin Proc"
                        },
                        "ce:source-text": "Steensma DP, Bennett JM (2006). The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc, 81, 104-30."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Suporn C TI, Noppadol S, Wichean M, et al (2011). Myelodysplastic syndrome guideline.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85122582984",
                                "@idtype": "SGR"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C TI",
                                        "@_fa": "true",
                                        "ce:surname": "Suporn",
                                        "ce:indexed-name": "Suporn C TI"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Noppadol",
                                        "ce:indexed-name": "Noppadol S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Wichean",
                                        "ce:indexed-name": "Wichean M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Myelodysplastic syndrome guideline"
                        },
                        "ce:source-text": "Suporn C TI, Noppadol S, Wichean M, et al (2011). Myelodysplastic syndrome guideline."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Wallvik J, Stenke L, Bernell P, et al (2002). Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes. Eur J Haematol, 68, 180-5.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0036270084",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "180",
                                    "@last": "185"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Wallvik",
                                        "ce:indexed-name": "Wallvik J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Stenke",
                                        "ce:indexed-name": "Stenke L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Bernell",
                                        "ce:indexed-name": "Bernell P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Haematol"
                        },
                        "ce:source-text": "Wallvik J, Stenke L, Bernell P, et al (2002). Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes. Eur J Haematol, 68, 180-5."
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85122570499",
        "dc:description": "Introduction: Erythropoiesis stimulating agents (ESAs) represents the principal treatments for anemia in patients with lower-risk myelodysplastic syndromes (MDS). Pre-treatment erythropoietin (EPO) level and previous bloodtransfusion requirement are the two major predictors for response to ESAs. However, most evidence was derivedfrom Western countries whereas there have been limited data in patients with Asian background. Methods: Weretrospectively collected data on patients with low-risk MDS who received ESAs. Erythroid response was evaluatedaccording to IWG 2006 criteria. MDS subtypes, r-IPSS, baseline hemoglobin (Hb), ESAs dosage and erythropoietinlevel were reviewed from medical records. Gene mutations were analyzed in patients\u2019 blood or bone marrow atdiagnosis by 40-gene myeloid panel targeted sequencing. Clinical and laboratory parameters were compared betweenerythroid responder and non-responder groups. Results: A total of 47 patients were recruited in the study. The medianage at diagnosis of the patients in this cohort was 77 years (IQR, 70-83) and 44.7% were male. The median revisedinternational prognostic scoring system (R-IPSS) score of patients was 2.5. Response rate to ESAs was 46.8% (22/47).Median EPO level in responders was significantly lower than non-responders (27.7 vs. 59.1 U/L, p=0.02). MedianESAs dosage in responder group was 30,000 units per week. Cytogenetic abnormalities were detected in 27.3% and24% of the responder and non-responder groups, respectively. Of 22 patients with available 40 gene mutation targetedsequencing, ASXL1, IDH2 and TET2 represented the 3 most common mutations and were found in 22%, 22% and17%, respectively. There were no differences in cytogenetic abnormalities and gene mutations between groups. Patientswho responded to ESAs showed a higher 5-year overall survival (OS) compared to non-responders (5-year OS 75%vs. 60.9%; p=0.008). Conclusion:We conclude that a low serum EPO level is a predictive factor for responsiveness toESAs in Asian patients with low-risk MDS",
        "pubmed-id": "34967586",
        "prism:coverDate": "2021-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85122570499",
        "dc:creator": {"author": [{
            "ce:given-name": "Saroj",
            "preferred-name": {
                "ce:given-name": "Saroj",
                "ce:initials": "S.",
                "ce:surname": "Hattakitpanitchakul",
                "ce:indexed-name": "Hattakitpanitchakul S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Hattakitpanitchakul",
            "@auid": "57406571100",
            "author-url": "https://api.elsevier.com/content/author/author_id/57406571100",
            "ce:indexed-name": "Hattakitpanitchakul S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85122570499"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122570499&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85122570499&origin=inward"
            }
        ],
        "source-id": "40173",
        "citedby-count": "0",
        "prism:volume": "22",
        "subtype": "ar",
        "dc:title": "Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes",
        "openaccess": "1",
        "prism:issn": "2476762X 15137368",
        "publishercopyright": "© This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License.",
        "prism:issueIdentifier": "12",
        "subtypeDescription": "Article",
        "prism:publicationName": "Asian Pacific Journal of Cancer Prevention",
        "prism:pageRange": "4037-4042",
        "prism:endingPage": "4042",
        "openaccessFlag": "true",
        "prism:doi": "10.31557/APJCP.2021.22.12.4037",
        "prism:startingPage": "4037",
        "dc:identifier": "SCOPUS_ID:85122570499",
        "dc:publisher": "Asian Pacific Organization for Cancer Prevention"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged, 80 and over",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Anemia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Asians",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Blood Transfusion",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Chromosome Aberrations",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Dioxygenases",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "DNA-Binding Proteins",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Erythropoietin",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hematinics",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Isocitrate Dehydrogenase",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Mutation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Myelodysplastic Syndromes",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Predictive Value of Tests",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prognosis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Repressor Proteins",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Retrospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Survival Rate",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Erythropoiesis stimulating agents"
        },
        {
            "@_fa": "true",
            "$": "Erythropoietin level"
        },
        {
            "@_fa": "true",
            "$": "Gene mutations"
        },
        {
            "@_fa": "true",
            "$": "Low"
        },
        {
            "@_fa": "true",
            "$": "Risk myelodysplastic syndromes"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Saroj",
            "preferred-name": {
                "ce:given-name": "Saroj",
                "ce:initials": "S.",
                "ce:surname": "Hattakitpanitchakul",
                "ce:indexed-name": "Hattakitpanitchakul S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Hattakitpanitchakul",
            "@auid": "57406571100",
            "author-url": "https://api.elsevier.com/content/author/author_id/57406571100",
            "ce:indexed-name": "Hattakitpanitchakul S."
        },
        {
            "ce:given-name": "Sirorat",
            "preferred-name": {
                "ce:given-name": "Sirorat",
                "ce:initials": "S.",
                "ce:surname": "Kobbuaklee",
                "ce:indexed-name": "Kobbuaklee S."
            },
            "@seq": "2",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Kobbuaklee",
            "@auid": "57211805681",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211805681",
            "ce:indexed-name": "Kobbuaklee S."
        },
        {
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "3",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        },
        {
            "ce:given-name": "Chantana",
            "preferred-name": {
                "ce:given-name": "Chantana",
                "ce:initials": "C.",
                "ce:surname": "Polprasert",
                "ce:indexed-name": "Polprasert C."
            },
            "@seq": "4",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Polprasert",
            "@auid": "56601214400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56601214400",
            "ce:indexed-name": "Polprasert C."
        }
    ]}
}}